About NightHawk Biosciences
NightHawk Biosciences is a company based in Morrisville (United States) founded in 2008. NightHawk Biosciences has raised $8.13 million across 9 funding rounds from investors including HHS. NightHawk Biosciences has completed 1 acquisition, including Pelican Therapeutics. NightHawk Biosciences operates in a competitive market with competitors including WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others.
- Headquarter Morrisville, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
$6.24 M (USD)-59as on Dec 31, 2024
-
Net Profit
-$32.81 M (USD)-1930as on Dec 31, 2024
-
EBITDA
-$33.6 M (USD)20as on Dec 31, 2024
-
Total Equity Funding
$8.13 M (USD)
in 9 rounds
-
Latest Funding Round
$399.11 K (USD), Grant
Sep 19, 2023
- Investors
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of NightHawk Biosciences
Unlock access to complete
Unlock access to complete
Funding Insights of NightHawk Biosciences
NightHawk Biosciences has successfully raised a total of $8.13M across 9 strategic funding rounds. The most recent funding activity was a Grant round of $399.11 thousand completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in NightHawk Biosciences
NightHawk Biosciences has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for NightHawk Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NightHawk Biosciences
NightHawk Biosciences has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Pelican Therapeutics.
Investment portfolio details for NightHawk Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developing antibody to stimulate memory CD8+ cytotoxic T cells for the treatment of cancer.
|
Locked | Locked | 2011 | Locked |
Complete acquisition details for NightHawk Biosciences
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - NightHawk Biosciences
Detailed financials for NightHawk Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nighthawk Biosciences Comparisons
Peer comparison for NightHawk Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NightHawk Biosciences
NightHawk Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of CRO and CDMO services
|
|
| Locked | Locked | Locked |
Laboratory testing and contract research services are provided globally.
|
|
| Locked | Locked | Locked |
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes
|
|
| Locked | Locked | Locked |
Branded and generic prescription drugs are developed, manufactured, and marketed.
|
|
| Locked | Locked | Locked |
Advisory, scientific, and medical communications provided for pharmaceutical industry.
|
|
| Locked | Locked | Locked |
Regulatory support, brand differentiation, and prototyping services are provided.
|
Detailed competitors of NightHawk Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nighthawk Biosciences
Complete news archive for NightHawk Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NightHawk Biosciences
NightHawk Biosciences was founded in 2008 and raised its 1st funding round 1 year after it was founded.
NightHawk Biosciences is headquartered in Morrisville, United States.
NightHawk Biosciences is a funded company, having raised a total of $8.13M across 9 funding rounds to date.
Annual revenue of NightHawk Biosciences is $6.24M as on Dec 31, 2024.
NightHawk Biosciences was founded in 2008 as a fully integrated biopharmaceutical company based in Morrisville, United States. Operations focus on the discovery, development, and commercialization of therapies in the biotechnology sector. Services encompass preclinical and clinical-stage programs targeting various diseases, with activities managed from U.S. facilities. The companys domain is nighthawkbio.com, supporting its pipeline advancement.
NightHawk Biosciences's top competitors include WuXi AppTec, ANI Pharmaceuticals and Aptar.
NightHawk Biosciences has made 1 acquisition, including Pelican Therapeutics.
NightHawk Biosciences has 1 investor. Key investors include HHS.